← Leaderboards
Basmattee Boodram
Loyola University Chicago
$4,816,495
Attributed
$8,052,354
Total exposure
4
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1M · FY2012–25$2M$1.5M$1M$500K$0
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$7,752,661 · 3
CDC$299,693 · 1
By mechanism
R01$7,752,661 · 3
U51$299,693 · 1
Top collaborators
- Harel Dahari9 shared
- Jonathan Ozik9 shared
Most similar at Loyola University Chicago
Same institution · by research overlap
- Susan L Uprichard$8,275,018
- Harel Dahari$6,227,500
- Jonathan Ozik$2,212,458
- Timothy Spear$153,954
- Liang Qiao$4,617,387
Others in their field
Top investigators on “Hepatitis C”
- Constance Ann Benson · University Of California, San Diego$171,085,251
- Sharon A Nachman · Johns Hopkins University$116,441,543
- Peter B. Gilbert · Fred Hutchinson Cancer Center$94,107,997
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$70,290,471
- Richard Douglas Moore · Johns Hopkins University$59,121,971
- Charles R Rinaldo · University Of Pittsburgh At Pittsburgh$46,122,050
Research focus
Hepatitis CDrug UsageIllinoisSocialViral HepatitisGeographyPublic HealthGeographic FactorRisk BehaviorsInjecting Drug UserUnited States Dept. Of Health And Human ServicesBehavioralCommunitiesHepatitis C IncidenceChicagoHepatitis C TransmissionComplexNeedle-Exchange ProgramsInjectionsHepatitis C PrevalenceResearch PersonnelCharacteristicsAffectLocation
Grant awards (17)
Computational modeling for HCV vaccine trial design and optimal vaccine-based combination interventions$678,903
R01 · FY2025 · AI
Computational modeling for HCV vaccine trial design and optimal vaccine-based combination interventions$695,569
R01 · FY2024 · AI
Computational modeling for HCV vaccine trial design and optimal vaccine-based combination interventions$708,050
R01 · FY2023 · AI
Computational modeling for HCV vaccine trial design and optimal vaccine-based combination interventions$759,667
R01 · FY2022 · AI
Contextual risk factors for hepatitis C among young persons who inject drugs$525,951
R01 · FY2021 · DA · contact PI
Computational discovery of effective hepatitis C intervention strategies$398,579
R01 · FY2021 · GM
Contextual risk factors for hepatitis C among young persons who inject drugs$615,121
R01 · FY2020 · DA · contact PI
Computational discovery of effective hepatitis C intervention strategies$397,172
R01 · FY2020 · GM
Contextual risk factors for hepatitis C among young persons who inject drugs$562,354
R01 · FY2019 · DA · contact PI
Computational discovery of effective hepatitis C intervention strategies$395,551
R01 · FY2019 · GM
Contextual risk factors for hepatitis C among young persons who inject drugs$7,927
R01 · FY2019 · DA · contact PI
Contextual risk factors for hepatitis C among young persons who inject drugs$647,748
R01 · FY2018 · DA · contact PI
Computational discovery of effective hepatitis C intervention strategies$397,037
R01 · FY2018 · GM
Contextual risk factors for hepatitis C among young persons who inject drugs$539,772
R01 · FY2017 · DA · contact PI
Computational discovery of effective hepatitis C intervention strategies$423,260
R01 · FY2017 · GM
Case Management and Linkage to Care Among Persons Who Inject Drugs$151,774
U51 · FY2013 · PS · contact PI
Case Management and Linkage to Care Among Persons Who Inject Drugs$147,919
U51 · FY2012 · PS · contact PI